Mayo Clinic experts research and test new treatments for focal segmental glomerulosclerosis (FSGS) through the Nephrology Collaborative Group. As a Mayo Clinic patient, you may be able to participate in a clinical trial.


See a list of publications on focal segmental glomerulosclerosis by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

Aug. 23, 2017
  1. Focal glomerulosclerosis. National Kidney Foundation. Accessed Aug. 14, 2016.
  2. Reiser J. Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis. Accessed Aug. 14, 2016.
  3. What is a kidney biopsy? National Kidney Foundation. Accessed Aug. 14, 2016.
  4. Brown A. Allscripts EPSi. Mayo Clinic, Rochester, Minn. July 15, 2016.
  5. Thomas LF (expert opinion). Mayo Clinic, Scottsdale/Phoenix, Ariz. Sept. 8, 2016.
  6. Scientific Registry of Transplant Recipients. Accessed Sept. 28, 2016.
  7. AskMayoExpert. Glomerular disease. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
  8. Cattran DC, et al. Treatment of primary focal segmental glomerulosclerosis. Accessed Sept. 28, 2016.